XML 34 R20.htm IDEA: XBRL DOCUMENT
v3.21.1

Stock Options | 3 Months Ended
--- | ---
Mar. 31, 2021
Stock Options [Abstract] |
STOCK OPTIONS | 14. STOCK OPTIONS On October 30, 2020, the Company issued an aggregate of 545,182 shares of common stock in lieu of unpaid salaries of certain employees and unpaid consulting fees under the 2016 Equity Incentive Plan, as amended, at a conversion price of $2 per share; the total amount of converted salaries and consulting fees was $1,090,361. On November 21, 2020, the Company has entered into acknowledgement agreements and stock option purchase agreements with these employees and consultant; pursuant to which the Company granted stock options to purchase 545,182 shares of the Company’s common stock in lieu of common stock. The options were vested at the grant date and become exercisable for 10 years from the grant date. Options issued and outstanding as of December 31, 2020, and their activities during the year then ended are as follows:
|  |  |  |  |  |  |  | Weighted- |  |  |  |
|  |  |  |  | Weighted- |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Contractual |  |  |  |
|  | Number of |  |  | Exercise |  |  | Life |  |  | Aggregate |
|  | Underlying Shares |  |  | Price Per Share |  |  | Remaining in Years |  |  | Intrinsic Value |
Outstanding as of January 1, 2020 |  |  | - |  |  | $ | - |  |  |  |  |  |  | $ |  |
Granted |  |  | 545,182 |  |  |  | 2.00 |  |  |  | 9.89 |  |  |  | 616,056 |
Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2020 |  |  | 545,182 |  |  |  | 2.00 |  |  |  | 9.89 |  |  | $ | 616,056 |
Exercisable as of December 31, 2020 |  |  | 545,182 |  |  |  | 2.00 |  |  |  | 9.89 |  |  | $ | 616,056 |
Vested and expected to vest |  |  | 545,182 |  |  | $ | 2.00 |  |  |  | 9.89 |  |  | $ | 616,056 |
The fair value of stock options granted for the year ended December 31, 2020 was calculated using the Black-Scholes option-pricing model applying the following assumptions:
|  | Year ended |
|  | December 31, 2020 |
Risk free interest rate |  |  | 0.38 | %
Expected term (in years) |  |  | 5.00 |
Dividend yield |  |  | 0 | %
Expected volatility |  |  | 89.01 | %
The weighted average grant date fair value of options granted during 2020 was $3.13. There are 2,812,949 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2020. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. Accordingly, the Company recognized stock-based compensation expense of $0 and $0 for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there were no unvested options.

X
- References No definition available. + Details
Name: | abvcd_StockOptionsAbstract
Namespace Prefix: | abvcd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | abvcd_StockOptionsTextBlock
Namespace Prefix: | abvcd_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration